Publicaciones en colaboración con investigadores/as de Universidad Católica San Antonio (53)

2026

  1. Antiphospholipid antibodies and cardiovascular thrombosis

    Nature Reviews Cardiology

  2. Characteristics and outcomes of acute pulmonary embolism among patients with polyvascular, single-vascular or no atherosclerotic disease: insights from RIETE

    Clinical Research in Cardiology, Vol. 115, Núm. 3, pp. 472-483

  3. Optimizing the Accuracy of Natural Language Processing Tools for Pulmonary Embolism Detection Through Integration with Claims Data: The PE-EHR+ Study

    Thrombosis and Haemostasis

  4. Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study

    eClinicalMedicine, Vol. 94

  5. Pulmonary Embolism–Attributed Hospitalization and Mortality in the United States, 2016-2022

    Journal of the American College of Cardiology, Vol. 87, Núm. 13, pp. 1535-1538

  6. Right ventricular dysfunction on echocardiography to predict mortality in acute pulmonary embolism: an individual patient data meta-analysis

    Journal of Thrombosis and Haemostasis, Vol. 24, Núm. 4, pp. 1377-1387

  7. Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study

    Therapeutic Advances in Neurological Disorders, Vol. 19

  8. Trends in 90-Day Mortality, Recurrent Venous Thrombosis, and Bleeding in Patients With Pulmonary Embolism

    Journal of the American College of Cardiology, Vol. 87, Núm. 13, pp. 1539-1542

2025

  1. A machine learning approach to identify patients at risk for long-term consequences after pulmonary embolism

    Scientific reports, Vol. 15, Núm. 1, pp. 32744

  2. Acute pulmonary embolism: A multimarker calculator to predict short-term outcomes

    European Heart Journal, Vol. 46, Núm. 45, pp. 4921-4929

  3. Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry

    American Journal of Hematology

  4. Clinical presentation and prognosis of acute symptomatic pulmonary embolism in patients with concomitant upper-extremity versus lower-extremity deep vein thrombosis

    Thorax, Vol. 80, Núm. 6, pp. 369-377

  5. Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE

    Research and Practice in Thrombosis and Haemostasis, Vol. 9, Núm. 8

  6. External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the Registro Informatizado Enfermedad TromboEmb?lica Registry

    Journal of Thrombosis and Haemostasis, Vol. 23, Núm. 12, pp. 3909-3919

  7. Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions

    Journal of the American College of Cardiology, Vol. 86, Núm. 14, pp. 1065-1087

  8. Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts

    Thrombosis Research

  9. Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports

    Thrombosis Research, Vol. 247

  10. Sex differences in treatment strategies for pulmonary embolism in older adults: The SERIOUS-PE study of RIETE participants and US Medicare beneficiaries

    Vascular Medicine (United Kingdom), Vol. 30, Núm. 1, pp. 58-66

  11. Superficial Vein Thrombosis: A Review

    JAMA, Vol. 334, Núm. 22, pp. 2020-2030

  12. Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 23, Núm. 2, pp. 556-564